Skip to main content
SpringerLink
Log in

Neue Therapieperspektiven bei der Therapie des frühen und metastasierten Mammakarzinoms

San Antonio Breast Cancer Symposium, 09.–13.12.2009

New therapeutic concepts for treatment of early and metastasized breast cancer

San Antonio Breast Cancer Symposium 9th-13th December 2009

  • Aktuelle Onkologie
  • Published:
Der Onkologe Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Literatur

  1. Sanofi-Aventis Fach-Pressekonferenz, 11.01.2010

  2. Prerez E et al (2009) Results of chemotherapy alone, with sequential or concurrent addition of 52 weeks of trastuzumab in the NCCTG N9831 HER2-positive adjuvant breast cancer trial. SABCS, Abstr. 80

  3. Paik S (2000) JNCI 92:1991 (NSABP B15)

  4. Slamon D et al (2007) Role of anthracycline-based therapy in the adjuvant treatment of breast cancer. SABCS, Abstr. 13

  5. Slamon D, Eiermann W et al (2009) Phase III randomized trial comparing doxorubicin and cyclophosphamide followed by docetaxel (AC→T) with doxorubicin and cyclophosphamide followed by docetaxel and trastuzumab (AC→TH) with docetaxel, carboplatin and trastuzumab (TCH) in Her2neu positive early breast cancer patients: BCIRG 006 study. SABCS, Abstr. 62

  6. Levine MN et al (1998) Randomized trial of intensive cyclophosphamide, epirubicin and fluorouracil chemotherapy compared with cyclophosphamide, methotrexate and fluorouracil in premenopausal women with node-positive breast cancer. JCO 16(8):2651–2658

    CAS  Google Scholar 

  7. Janni W et al (2009) Sequential treatment with epirubicin/cyclophosphamide, followed by docetaxel is equieffective, but less toxic than FEC120 in the adjuvant treatment of breast cancer patients with extensive lymph node involvement: The German ADEBAR phase III study. SABCS, Abstr. 604, Poster Discussion 6; A603; SABCS 2009

  8. Ewerzt M et al (2009) Effect of obesity on prognosis after early breast cancer. SABCS Abstr. 18

  9. Kwan ML et al (2009) Alcohol and breast cancer survival in a prospective cohort study. SABCS Abstr. 17

  10. http://www.success-studie.de/

Download references

Interessenkonflikt

Der korrespondierende Autor gibt an, dass kein Interessenkonflikt besteht.

Author information

Authors and Affiliations

  1. Sellscheid 100, 42929, Wermelskirchen, Deutschland

    A. Junker

Authors
  1. A. Junker
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to A. Junker.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Junker, A. Neue Therapieperspektiven bei der Therapie des frühen und metastasierten Mammakarzinoms. Onkologe 16, 420–422 (2010). https://doi.org/10.1007/s00761-010-1814-x

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00761-010-1814-x

Search

Navigation